Lyme central nervous system infection IgG with antibody index reflex, serum and spinal fluid

Alphabetical Test listing

Lyme central nervous system infection IgG with antibody index reflex, serum and spinal fluid-994

  
Lyme central nervous system infection IgG with antibody index reflex, serum and spinal fluid
  
994
  
LAB994
  
MSO
  
Lyme antibody, CSF
Lyme serology, CSF
Neuroinvasive Lyme Disease
Neuroborreliosis
Lyme Disease in the Central Nervous System
Lyme CNS Disease
  

Aiding in the diagnosis of neuroinvasive Lyme disease or neuroborreliosis due to Borrelia species associated with Lyme disease (eg, B burgdorferi, B garinii, B afzelli)

  • This test should be ordered in patients with suspected neuroinvasive Lyme disease.
  • Although a small percentage of patients with neuroinvasive Lyme disease may be seronegative, it is recommended that all patients test by the Lyme Antibody Index assay also have standard 2-tiered testing for Lyme disease performed on serum.
  • This test compares the level of IgG antibodies to Lyme disease-causing Borrelia species in spinal fluid (CSF) and serum. The level of anti-Borrelia species IgG is normalized to total IgG and albumin in CSF and serum.
  • This test can help identify whether the presence of IgG to Borrelia species in the CSF is due to true intrathecal antibody synthesis, suggesting neuroinvasive Lyme disease, versus antibody presence due to passive diffusion through the blood-brain barrier or possibly, due to blood contamination of the CSF as a result of a traumatic lumbar puncture
  
Cerebrospinal fluid (CSF) and Serum
  

CSF - sterile vial/container

Serum - Gold serum separator (SST) tube

  
1.5 mL CSF and 1.5 mL serum
  
1.2 mL CSF and 1.2 mL serum
  

Spinal fluid (CSF)

  1. A spinal fluid sample of 1.5 mL needs to be collected within 24 hours of the serum specimen, preferably at the same time.
  2. Label vial as spinal fluid or CSF.
  3. CSF aliquot should be from the second, third, or fourth CSF vial collected during the lumbar puncture.

- Do not submit CSF from the first vial due to the possibility of blood contamination, which will cause specimen rejection.

  1. Band specimens together.

 

Serum:

  1. A serum sample of 1.5 mL needs to be collected within 24 hours of the spinal fluid specimen, preferably at the same time.
  2. Label as serum.
  3. Band specimens together.
  

Gold serum separator (SST) tube - spin

Following centrifucation of the SST tube, Rubberband the CSF vial and SST tube together.

  

Sterile vial and Gold serum separator (SST) tube

  
  

Spin and separate

Once the serum is transferred to a Screw cap transfer vial/tube (Mayo T465), rubberband the CSF  and serum transfer vials together.

  
  
Specimen Type Temperature Time
CSF Refrigerated (preferred) 11 days
  Frozen  35 days
Serum Refrigerated (preferred) 11 days
  Frozen  35 days
  

Serum:

  • Gross hemolysis
  • Gross lipemia

CSF:

  • Contaminated with blood
  
Mayo Clinic Laboratories (LNBAB): R-NX
  
Mo, We, Fr: 8 am
  
2 - 4 days
  

The test kit contains microtiter strips with break-off reagent wells coated with a mix of Bb sl antigens (whole antigen extracts of Borrelia burgdorferi sensu stricto, B afzelii, B garinii and recombinant VlsE of B burgdorferi sensu stricto). In the first reaction step, diluted patient samples are incubated in the wells. In the case of positive samples, Borrelia-specific-IgG antibodies will bind to the antigens. To detect the bound antibodies, a second incubation is carried out using an enzyme-labelled antihuman IgG (enzyme conjugate), followed by a third incubation using chromogen/substrate (TMB/H2O2), which catalyzes a color reaction that is then measured for optical density (OD) using spectrophotometry. The obtained OD values of the paired patient serum and spinal fluid samples are compared against a 6-level calibration curve to quantitatively determine the relative anti-Borrelia IgG antibody titers.(Package insert: Antibodies of the IgG class against Borrelia in cerebrospinal fluid, Euroimmun Ag, Seekamp 31, 23560 Luebeck, Germany 06/15/2015)

  

Negative

 

 

 

  

Interpretation

Negative:

No antibodies to Lyme disease causing Borrelia species detected in spinal fluid. A negative result in a patient with appropriate exposure history and symptoms consistent with neuroinvasive Lyme disease should not be used to exclude infection. Testing for antibodies to Lyme disease-causing Borrelia species in serum should be performed.

Reactive:

Supplemental testing to determine a Lyme central nervous system antibody index has been ordered. Diagnosis of neuroinvasive Lyme disease should not be established solely based on a reactive screening result.

  
86618

Additional CPT codes (If applicable):86618 x 2
82040
82042
82784 x 2
  
12/23/2019
  
07/16/2020